Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Between-hospital variation in discontinuation of treatment with dimethyl fumarate in multiple sclerosis.
Staying afloat with OCEAN traits: The five-factor model of personality and psychological resilience in multiple sclerosis.
[Practice of obstetric medicine in neurological disorders: towards evidence-based shared decision-making (SDM)].
Diabetes and the Nervous System: Linking Peripheral Neuropathy to Central Neurodegeneration.
Natalizumab and Tyruko (natalizumab biosimilar) for treating highly active relapsing-remitting multiple sclerosis after at least one disease-modifying therapy: a systematic review and economic model.
Key genetic biomarkers and therapeutic potential in multiple sclerosis: Insights from integrated bioinformatics and mendelian randomization.
Pyroptosis in Alzheimer's disease: Mechanisms and neuroinflammatory networks.
Myelin and Oligodendrocyte Dysfunction in Demyelinating and Neurodegenerative Disorders: Signaling Pathways and Therapeutic Targets.
Alzheimer's disease polygenic risk score associates with hippocampal subfield atrophy and immune-related genetic mechanism.
2,6-diaminopurine enhances Aqp4 stop codon readthrough and perivascular localization in the brain.
Longitudinal Neurofilament Light Chain Z-Score Dynamics: Bridging the Gap Between Research and Routine Monitoring in Multiple Sclerosis.
The Prognostic Value of Paramagnetic Rim Lesions in People With Multiple Sclerosis.
Imposters in the MS clinic: Adult-onset inherited white matter disorders.
Inebilizumab in AQP4-Seropositive NMOSD: One-Year Follow-Up From a Multicenter, Real-World Study.
Decoding the Neuroinflammatory Potential of Non-Nutritive Sweeteners Through An Integrative Computational Approach.
Clinical and Experimental Insights into Hydroxychloroquine-Associated Electrical Abnormalities and Cardiomyopathy.
Native structure of the therapeutic IgG4 α4β5 integrin antibody natalizumab.
Extracellular Vesicle-Associated miRNA in Multiple Sclerosis Subtypes: Differential Profiles in Secondary Progressive Disease and the Effect of One-Year Siponimod Treatment.
MRI-Based Quantitative Assessment of Normal-Appearing White and Gray Matter Demyelination in Multiple Sclerosis, Parkinson's Disease, Long COVID, and Normal Aging.
Contribution of thalamus-cortex network and cortical habituation mechanisms in multiple sclerosis.
ATF3/SLC31A1-Mediated Cuproptosis Contributes to Bortezomib-Induced Peripheral Neurotoxicity and Intervention by (-)-Epigallocatechin Gallate.
Assessing the value of oligoclonal band count in multiple sclerosis: insights from a large cohort analysis.
Acupuncture for the treatment of Delayed Encephalopathy after Acute Carbon Monoxide Poisoning: a case report.
Chimeric antigen receptor T-cell therapy in neurological disorders: Emerging applications, evidence, and challenges.
Fatigue and contributing factors in relapsing-remitting multiple sclerosis: a descriptive study based on the comprehensive fatigue assessment battery for multiple sclerosis (CFAB-MS).

Pages